EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrated multi-omics identifies lineage-dependent myeloid cells recruitment and the APP-CD74 axis as an immunoregulatory target in pediatric high-grade glioma

Zhuang Wang, Ambuj Kumar, Banlanjo Umaru, Archana Mahadevan Iyer, Komal Khan, Hao-Han Pang, Maryam Fouladi, Rachid Drissi iD

Acta Neuropathologica · 2026

DOI: 10.1007/s00401-026-03089-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Neuropathologica, 2026. Verfasst von Zhuang Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Childhood Cancer Research, Nationwide Children's Hospital, 575 Children's Crossroad, Columbus, OH, USA. Hauptthemen laut MEDLINE: Antigens, Differentiation, B-Lymphocyte, Histocompatibility Antigens Class II, Glioma, Amyloid beta-Protein Precursor. Die Arbeit nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CancerFree Kids New Idea Grant, Pelotonia Kids, The Cure Starts Now Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diffuse intrinsic pontine glioma (DIPG) is a devastating pediatric brain tumor with limited treatment options. Emerging evidence indicates infiltration of tumor-associated macrophages (TAMs) within tumor sites, accompanied by an immunosuppressive tumor microenvironment (TME). However, the mechanisms underlying macrophage recruitment and communication between TAMs and other cellular compartments within brain tumors remain poorly understood. Bulk RNA sequencing of 26 DIPG autopsy specimens with matched normal brain tissue, single-cell RNA sequencing data from eight DIPG patients integrated with public pediatric high-grade glioma (pHGG) datasets, and in vitro transwell and flow cytometry assays collectively indicated that DIPG tumors actively recruit monocytes through chemokine-mediated mechanisms. The chemokine expression of tumor cells is driven by a mesenchymal-like (MES-like) lineage state rather than histone mutations, as evidenced by significant correlation between MES-like lineage scores and chemokine expression scores across 46 pHGG cell lines. CellChat analysis predicted APP-CD74 signaling as a prominent tumor cell-TAM interaction pathway, supported by immunofluorescence validation. Notably, APP expression was significantly reduced in DIPG tumor tissues compared with normal brain tissue at both the RNA and protein levels. Recombinant APP stimulation of THP-1-derived macrophages induced a robust proinflammatory response, including upregulation of M1-like markers, enrichment of interferon-related pathways, and elevated secretion of inflammatory cytokines. Collectively, these findings suggest that reduced APP expression in tumor may contribute to a non-inflammatory TAM phenotype and an immunosuppressive microenvironment. Furthermore, protein modeling and docking analyses identified the APP-CD74 binding interface, providing a structural basis for therapeutic targeting.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antigens, Differentiation, B-LymphocyteHistocompatibility Antigens Class IIGliomaAmyloid beta-Protein PrecursorMyeloid CellsDiffuse Intrinsic Pontine GliomaBrain Stem NeoplasmsBrain NeoplasmsHumansChildTumor MicroenvironmentFemaleSignal TransductionMaleCell Line, TumorChild, PreschoolCell LineageTumor-Associated Macrophages

Stichwörter der Autor:innen

Amyloid precursor protein (APP)CD74Diffuse intrinsic pontine glioma (DIPG)Pediatric high-grade glioma (pHGG)Tumor-associated macrophages (TAMs)

Substanzen

invariant chainAntigens, Differentiation, B-LymphocyteHistocompatibility Antigens Class IIAmyloid beta-Protein Precursor

Autor:innen und Institutionen

  • Center for Childhood Cancer Research, Nationwide Children's Hospital, 575 Children's Crossroad, Columbus, OH, USA.
  • Center for Drug Research and Development, Chang Gung University of Science and Technology, Taoyuan, Taiwan.
  • Pediatric Neuro-Oncology Program, Nationwide Children's Hospital, Columbus, OH, USA.
  • College of Medicine, The Ohio State University, Columbus, OH, USA.
  • Center for Childhood Cancer Research, Nationwide Children's Hospital, 575 Children's Crossroad, Columbus, OH, USA. Rachid.Drissi@nationwidechildrens.org.
  • College of Medicine, The Ohio State University, Columbus, OH, USA. Rachid.Drissi@nationwidechildrens.org.

ORCID-Profile: Rachid Drissi

Förderung

  • CancerFree Kids New Idea Grant
  • Pelotonia Kids
  • The Cure Starts Now Foundation
  • Nationwide Children’s Hospital Startup Funding

Zitieren

APA

Wang, Z., Kumar, A., Umaru, B., Iyer, A. M., Khan, K., Pang, H. H., Fouladi, M., & Drissi, R. (2026). Integrated multi-omics identifies lineage-dependent myeloid cells recruitment and the APP-CD74 axis as an immunoregulatory target in pediatric high-grade glioma. Acta Neuropathologica. https://doi.org/10.1007/s00401-026-03089-0

Vancouver

Wang Z, Kumar A, Umaru B, Iyer AM, Khan K, Pang HH, et al. Integrated multi-omics identifies lineage-dependent myeloid cells recruitment and the APP-CD74 axis as an immunoregulatory target in pediatric high-grade glioma. Acta Neuropathologica. 2026. doi:10.1007/s00401-026-03089-0

BibTeX
@article{Wang2026,
  author = {Wang, Zhuang and Kumar, Ambuj and Umaru, Banlanjo and Iyer, Archana Mahadevan and Khan, Komal and Pang, Hao-Han and Fouladi, Maryam and Drissi, Rachid},
  title = {Integrated multi-omics identifies lineage-dependent myeloid cells recruitment and the APP-CD74 axis as an immunoregulatory target in pediatric high-grade glioma},
  journal = {Acta Neuropathologica},
  year = {2026},
  doi = {10.1007/s00401-026-03089-0}
}
Kostenlos starten →